Ronald M. Razmi - 27 Apr 2022 Form 4 Insider Report for Deep Medicine Acquisition Corp. (DMAQ)

Role
Director
Signature
/s/ Ronald M. Razmi
Issuer symbol
DMAQ
Transactions as of
27 Apr 2022
Transactions value $
$0
Form type
4
Filing time
27 Apr 2022, 16:32:28 UTC
Previous filing
26 Oct 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DMAQ Class B Common Stock Other $0 +50,000 $0 50,000 27 Apr 2022 Class A Common Stock 50,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As described in the registrant's registration statement on Form S-1 (File No. 333-259500) under the heading "Description of Securities - Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the registrant's initial business combination, or earlier at the option of the holder, on a one-for-one basis subject to certain adjustments and have no expiration date.
F2 Pursuant to certain redemption agreement between Bright Vision Sponsor LLC (the "Sponsor") and Ronald M. Razmi, a member of the Sponsor, shares of Class B common stock of the registrants were transferred by the Sponsor to Mr. Razmi in consideration for the redemption of such membership interest of the Sponsor entitling Mr. Razmi to receive such securities.